Stay updated on Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 added. The previous Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-21T08:44:57.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:15.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.1 to v3.4.2. No changes to study details, eligibility criteria, outcomes, or participating locations.
    Difference
    0.0%
    Check dated 2026-02-13T12:32:50.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T14:59:13.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Show glossary feature added; the page now displays a glossary toggle. The QC status label has changed to 'Last Update Submitted that Met QC Criteria' and policy text to 'No FEAR Act Data' with a new revision tag 'v3.4.0' (replacing 'v3.3.4').
    Difference
    0.2%
    Check dated 2026-01-29T06:51:38.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; this is a minor site update that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:12:32.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.